|
Re: Resverlogix Provides Update on BETonMACE Phase 3 Trial
|
3
|
Resverlogix Corp.
|
Sep 16, 2019 10:28AM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Aug 18, 2019 07:04PM
|
|
Re: Insider selling - timeline
|
3
|
Resverlogix Corp.
|
Aug 28, 2019 09:15AM
|
|
Re: Sedar filings - Loan balance
|
4
|
Resverlogix Corp.
|
Jul 30, 2019 02:56PM
|
|
Re: Nice run for Hepa over the holidays
|
4
|
Resverlogix Corp.
|
Jan 06, 2020 09:33AM
|
|
Re: Clarification on BETonMACE baseline data
|
4
|
Resverlogix Corp.
|
Sep 09, 2019 06:36PM
|
|
Re: A birthday present for DM?
|
4
|
Resverlogix Corp.
|
Aug 20, 2019 08:21PM
|
|
Re: Years ago
|
4
|
Resverlogix Corp.
|
Feb 13, 2020 02:22PM
|
|
Re: Naz listing?
|
4
|
Resverlogix Corp.
|
Apr 20, 2019 10:30AM
|
|
Re: Patient Years & MACE rate Question
|
4
|
Resverlogix Corp.
|
Jul 11, 2019 12:16PM
|
|
Re: Take Home Points: not ready for use in patients
|
4
|
Resverlogix Corp.
|
Nov 16, 2019 05:50PM
|
|
Re: BIO CEO Slides Up
|
4
|
Resverlogix Corp.
|
Sep 18, 2019 06:31PM
|
|
Re: Position Sizing and Odds of Success
|
4
|
Resverlogix Corp.
|
Apr 25, 2019 08:35PM
|
|
Re: ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
4
|
Resverlogix Corp.
|
Sep 03, 2019 05:42PM
|
|
China Market
|
4
|
Resverlogix Corp.
|
Nov 03, 2019 11:49AM
|
|
Re: Apabetalone publication in "Current Opinion in Nephrology & Hypertension"
|
4
|
Resverlogix Corp.
|
Jan 30, 2020 08:44AM
|
|
Re: Vitamin D and Omega 3 don’t preserve renal fxn in Type 2 DM
|
4
|
Resverlogix Corp.
|
Nov 12, 2019 10:59AM
|
|
Re: Late Breaker program?
|
4
|
Resverlogix Corp.
|
Mar 22, 2020 11:21PM
|
|
Re: Looking for clues:
|
4
|
Resverlogix Corp.
|
Nov 30, 2019 04:54AM
|
|
Re: Can someone tell me why this news today is not NR worthy?
|
4
|
Resverlogix Corp.
|
Dec 06, 2019 10:05AM
|
